Author:
Krüger Falk Mads,Kemp Henrik,Sørensen Torben Lykke
Reference16 articles.
1. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006
2. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study;Brown;Ophthalmology,2009
3. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration;Fung;Am J Ophthalmol,2007
4. Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy;Kumar;Br J Ophthalmol,2011
5. Hjelmqvist L, Lindberg C, Kanulf P, Dahlgren H, Johansson I, Siewert A. One-year outcomes using ranibizumab for neovascular age-related macular degeneration: results of a prospective and retrospective observational multicentre study. J Ophthalmol. Forthcoming.
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献